Risdiplam

CHEBI:CHEBI_754031

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2390946
generic_name
Risdiplam
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
route
ORAL
marketing_start_date
20200807
package_marketing_start_date
20200807
nui
N0000194060
pharm_class_moa
Survival of Motor Neuron 2 Splicing Modifiers [MoA]
pharm_class
Survival of Motor Neuron 2 Splicing Modifiers [MoA]
dosage_form
POWDER, FOR SOLUTION
active_ingredient_strength
.75 mg/mL
pharm_class_pe
Increased Protein Synthesis [PE]
brand_name
EVRYSDI
brand_name_base
EVRYSDI
product_ndc
50242-175
application_number
NDA213535
labeler_name
Genentech Inc.
manufacturer_name
Genentech Inc.
spl_id
f3fe8978-af78-4fb1-a916-6687f5de8bdf
active_ingredient_name
RISDIPLAM
package_ndc
50242-175-07
package_description
1 BOTTLE, GLASS in 1 CARTON (50242-175-07) / 80 mL in 1 BOTTLE, GLASS
unii
76RS4S2ET1
spl_set_id
eceb9a99-7191-4be5-87c3-0102707cf98e
pharm_class_epc
Survival of Motor Neuron 2 Splicing Modifier [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class